Photothermal killing of Staphylococcus aureus using antibody-targeted gold nanoparticles

Purpose The continued emergence of multidrug resistant bacterial infections and the decline in discovery of new antibiotics are major challenges for health care throughout the world. This situation has heightened the need for novel antimicrobial therapies as alternatives to traditional antibiotics. The combination of metallic nanoparticles and laser exposure has been proposed as a strategy to induce physical damage to bacteria, regardless of antibiotic sensitivity. The purpose of this study was to test the antibacterial effect of antibody-targeted gold nanoparticles combined with pulsed laser irradiation. Methods Gold nanoparticles conjugated to antibodies specific to Staphylococcus aureus peptidoglycan were incubated with suspensions of methicillin-resistant and methicillin-sensitive S. aureus (MRSA and MSSA). Bacterial suspensions were then exposed to 8 ns pulsed laser irradiation at a wavelength of 532 nm and fluences ranging from 1 to 5 J/cm2. Viability of the bacteria following laser exposure was determined using colony forming unit assays. Scanning electron microscopy was used to confirm the binding of nanoparticles to bacteria and the presence of cellular damage. Results The laser-activated nanoparticle treatment reduced the surviving population to 31% of control in the MSSA population, while the survival in the MRSA population was reduced to 58% of control. Significant decreases in bacterial viability occurred when the laser fluence exceeded 1 J/cm2, and this effect was linear from 0 to 5 J/cm2 (r2=0.97). Significantly less bactericidal effect was observed for nonfunctionalized nanoparticles or functionalized nanoparticles without laser activation. Conclusion Laser-activated nanoparticles targeted to S. aureus surface antigens significantly reduced the percentage of viable organisms and represents a promising new treatment modality that could be used either alone or as an adjunct to existing, conventional antibiotic therapy.

[1]  B. Limbago,et al.  Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Lew,et al.  Good statistical practice in pharmacology Problem 2 , 2007, British journal of pharmacology.

[3]  D. Talan,et al.  Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. , 2013, The Journal of emergency medicine.

[4]  V. Zharov,et al.  In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles , 2012, PloS one.

[5]  Michael R Hamblin,et al.  Photodynamic therapy for methicillin‐resistant Staphylococcus aureus infection in a mouse skin abrasion model , 2010, Lasers in surgery and medicine.

[6]  M. J. Kim,et al.  Rapid photothermal lysis of the pathogenic bacteria, Escherichia coli using synthesis of gold nanorods. , 2009, Journal of nanoscience and nanotechnology.

[7]  Charles Joenathan,et al.  Laser-induced explosion of gold nanoparticles: potential role for nanophotothermolysis of cancer. , 2006, Nanomedicine.

[8]  C M Macal,et al.  The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Anant Kumar Singh,et al.  Rapid colorimetric identification and targeted photothermal lysis of Salmonella bacteria by using bioconjugated oval-shaped gold nanoparticles. , 2010, Chemistry.

[10]  Vladimir P Zharov,et al.  Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. , 2006, Biophysical journal.

[11]  Nalinikanth Kotagiri,et al.  Photothermal antimicrobial nanotherapy and nanodiagnostics with self‐assembling carbon nanotube clusters , 2007, Lasers in surgery and medicine.

[12]  Yu-Chie Chen,et al.  Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. , 2007, Nanomedicine.

[13]  T. Ohta,et al.  Overexpression of Sigma Factor, ςB, Urges Staphylococcus aureus to Thicken the Cell Wall and to Resist β-Lactams , 2001 .

[14]  T. Ohta,et al.  Overexpression of sigma factor, sigma(B), urges Staphylococcus aureus to thicken the cell wall and to resist beta-lactams. , 2001, Biochemical and biophysical research communications.

[15]  J. Yamagishi,et al.  Mechanisms of action of acriflavine: electron microscopic study of cell wall changes induced in Staphylococcus aureus by acriflavine , 2009, Microbiology and immunology.

[16]  P. Jain,et al.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.

[17]  Younan Xia,et al.  Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery , 2010, Expert opinion on drug delivery.

[18]  Anand Gole,et al.  Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. , 2008, Nano letters.

[19]  Fatemeh Shakeri,et al.  Spa Diversity among MRSA and MSSA Strains of Staphylococcus aureus in North of Iran , 2010, International journal of microbiology.

[20]  Michael Wilson,et al.  Antibody-directed photodynamic therapy of methicillin resistant Staphylococcus aureus. , 2004, Microbial drug resistance.

[21]  J. West,et al.  Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer , 2010, International journal of nanomedicine.

[22]  H. Chambers,et al.  Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  A. Edwards,et al.  Methicillin Resistance Reduces the Virulence of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus by Interfering With the agr Quorum Sensing System , 2012, The Journal of infectious diseases.

[24]  H. Boucher,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Otter,et al.  Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. , 2011, The Journal of hospital infection.

[26]  Rebekah Drezek,et al.  In vivo biodistribution of nanoparticles. , 2011, Nanomedicine.

[27]  G. Oster,et al.  Trends in US Hospital Admissions for Skin and Soft Tissue Infections , 2007, Emerging infectious diseases.